Evoq Remedies Share Price

Small Cap | Pharmaceuticals and health care | BSE: 543500

₹5.52 image-1.38 (-20.00 %)

Last Updated: 21 Feb 2025 04:01 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 7.70

High (₹) 8.28

Low (₹) 5.52

Prev. Close (₹) 6.90

Volume 21,24,000

VWAP (₹) 6.18

ROCE (%) 2.42

Industry P/E 43.99

TTM P/E 30.67

P/B Ratio 0.30

Market Cap (₹) Cr.13.74

Dividend Yield (%)--

EPS (₹) 0.03

ROE0.16%

Sales Growth (%) -80.12

Profit Growth (%)-72.06

Day Range

8.288.28

L
H

52 Week Range

5.5213.51

L
H

Historical Returns

Returns (6M)

-39.41 %

Returns (1Y)

-58.65 %

Returns (3Y)

-76.76 %

Returns (5Y)

-76.76 %

Returns (6M)

-39.41 %

Returns (1Y)

-58.65 %

Returns (3Y)

-76.76 %

Returns (5Y)

-76.76 %

SWOT Analysis

No data available

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 52.71

MFI 11.55

ATR 0.69

Commodity Channel Index -79.53

ROC125 -39.67

ROC21 -23.33

Williams %R -100.00

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current7.369.2010.126.444.603.681.84
Week Ago6.596.616.626.586.566.556.53
Month Ago7.347.477.547.277.147.076.94

EMA & SMA
info_icon

5.52

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 6.28


9 Day 6.56


10 Day 6.54


12 Day 6.61


14 Day 6.64

20 Day 6.77


26 Day 6.90


50 Day 7.37


100 Day 7.72


200 Day 8.79

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
SETU SECURITIES PVT. LTD.bulkSell21 Feb, 2025₹5.5284,000BSE
PUJABAHEN BAROTbulkSell21 Feb, 2025₹5.9012,96,000BSE
PRIYASHA MEVEN FINANCE LTD.bulkSell21 Feb, 2025₹5.641,36,000BSE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDbulkSell21 Feb, 2025₹5.5268,000BSE
SETU SECURITIES PVT. LTD.bulkBuy21 Feb, 2025₹5.622,00,000BSE
PRIYASHA MEVEN FINANCE LTD.bulkBuy21 Feb, 2025₹5.621,36,000BSE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDbulkBuy21 Feb, 2025₹5.532,00,000BSE
NEETA TAYALbulkSell05 Jul, 2024₹10.4880,000BSE
NISHA TAYALbulkSell12 Mar, 2024₹10.6672,000BSE
NEETA TAYALbulkBuy12 Mar, 2024₹10.6672,000BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
12 Jan, 2024PAYAL BHUMISHTH PATELDisposal₹17.1070562770562770562770562818,48,000BSE
12 Jan, 2024BHUMISHTH NARENDRABHAI PATELDisposal₹16.6180522875816993464052287630,60,000BSE
11 Jan, 2024PAYAL BHUMISHTH PATELDisposal₹16.2011,52,000BSE
11 Jan, 2024BHUMISHTH NARENDRABHAI PATELDisposal₹16.2011,48,000BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
07 Nov, 2022Rights issue of equity shares of Rs. 10/- in the ratio of 18:5 @ par.01 Jan, 197001 Jan, 1970

Announcements

DateSourceDetail
20 Feb, 2025BSE IndiaIntimation under Regulation 30 of SEBI (LODR), Regulation, 2015
21 Jan, 2025BSE IndiaIntimation of appointment of Statutory Auditor of the Company
21 Jan, 2025BSE IndiaPursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations,\r\n2015, we hereby inform you that the Board of Directors in their meeting held today i.e. Tuesday, 21st\r\nJanuary, 2025 at the Registered Office of the Company situated at A-1106, Empire Business Hub Near\r\nAUDA Water Tank, Science City Road, Sola, Ahmedabad - 380 060 which commenced at 05:00 P.M. and\r\nconcluded at 07:15 P.M. has considered and approved Appointment of M/s. H Thakkar & Co. LLP,\r\n(FRN: W100891), Mumbai, as the Statutory Auditor of the Company on the recommendation of Audit\r\nCommittee for the Financial Year 2024-25, subject to approval of the members in the General Meeting\r\nwithin three months from the date of appointment by the Board of Directors.
16 Dec, 2024BSE IndiaAs per Intimation attached here with.
28 Nov, 2024BSE IndiaKindly find the attached intimation
14 Oct, 2024BSE IndiaKindly find attached certificate under Regulation 74(5) of the SEBI (Depository and Participant) Regulations, 2018
01 Oct, 2024BSE IndiaAnnouncement under regulation 30 - General Announcement
01 Oct, 2024BSE IndiaAnnouncement under Regulation 30 (LODR) - Resignation of Independent director
01 Oct, 2024BSE IndiaAnnouncement under regulation 30 (LODR) - Change in Directorate
01 Oct, 2024BSE IndiaPursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations,\r\n2015, we hereby inform you that the Meeting Board of Directors of the Company held today i.e.,\r\nTuesday, 1st October 2024 at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road,\r\nSola Ahmedabad, Gujarat, India - 380 060 which commenced at 5:00 P.M. and concluded at 6:00 P.M.,\r\ninter-alia has considered and approved:\r\n1. Appointment of Ms. Aesha Harsh Shah (DIN: 10423365) as Additional Non-Executive\r\nIndependent Director of the Company w.e.f 1st October, 2024.\r\n2. Resignation of Mr. Pranav Manoj Vajani (DIN: 09213749) from Independent Director of the\r\nCompany w.e.f 1st October, 2024.\r\n3. Reconstitution of the Audit Committee of the Company w.e.f. 1st October, 2024\r\n4. Reconstitution of the Nomination and Remuneration Committee of the Company w.e.f. 1st October,\r\n2024

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Audited Results--22 May, 202427 May, 2024
Preferential issue of shares--17 Jan, 202422 Jan, 2024
Half Yearly Results(Revised)09 Nov, 202310 Nov, 2023
Half Yearly Results--09 Nov, 202308 Nov, 2023
Audited Results--11 May, 202325 May, 2023
Half Yearly Results & Rights issue--02 Nov, 202207 Nov, 2022
Audited Results--25 May, 202230 May, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameSept, 2024Jun, 2024Mar, 2024Sept, 2023

About Evoq Remedies

Evoq Remedies is a Public Limited Listed company incorporated on 24/02/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2010PLC059692 and registration number is 059692. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 4.05 Cr. and Equity Capital is Rs. 13.60 Cr. for the Year ended 31/03/2024.  Read More

Parent Organisation

Not Applicable

Founded

2010

Managing Director

Mr. Bhumishth Patel

NSE Symbol

--

Evoq Remedies Management

NameDesignation
Mr. Bhumishth PatelManaging Director
Mr. Narendrakumar PatelNon Executive Director
Mr. Pranav VajaniIndependent Director
Mr. Harsh KothariIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
SunPhrmInds₹4,46,576.22₹1,643.75 image
₹1,669.30(-1.53%)
₹1,249.800 - ₹1,960.200
Divis Labora₹1,56,123.40₹5,757.05 image
₹5,978.30(-3.70%)
₹3,350.050 - ₹6,448.750
Cipla₹1,21,675.13₹1,475.75 image
₹1,479.70(-0.27%)
₹1,240.700 - ₹1,702.000
ManKind Phar₹1,18,478.90₹2,327.75 image
₹2,348.45(-0.88%)
₹1,910.100 - ₹3,050.000
DrReddysLab₹1,15,939.04₹1,151.80 image
₹1,170.95(-1.64%)
₹1,104.690 - ₹1,420.200

FAQs on Evoq Remedies

What is the share price of Evoq Remedies?

The share price of Evoq Remedies on 21 Feb, 2025 is ₹ 5.52.

What is 52W high and 52W low share price of Evoq Remedies?

The highest and lowest 52W share prices of Evoq Remedies are ₹ 19.440 and ₹ 7.170

What is the market cap of Evoq Remedies?

The market capitalization of Evoq Remedies as of 21 Feb, 2025 is ₹ 13.74 Crores

What is the P/E ratio of Evoq Remedies?

The current P/E ratio of Evoq Remedies as of 21 Feb, 2025 is 43.99

What is the PB ratio of Evoq Remedies?

The PB ratio of Evoq Remedies as of 21 Feb, 2025 is 0.30

Top Gainers

948IHFL26I

IBHFL NCD186

₹845.00image

₹705.00 (0.20%)

GREAVESCOT

Greaves

₹281.85image

₹234.90 (0.20%)

ASHSI

Ashirwd Stl

₹45.66image

₹38.05 (0.20%)

CAPRO

Caprola.Chem

₹62.40image

₹52.00 (0.20%)

Top Losers

DHANBANK

Dhanalak.Bnk

₹32.19image

₹35.97 (-0.11%)

08MPD

08MPD

₹8.66image

₹9.62 (-0.10%)

BALTE

BalurghtTran

₹27.13image

₹31.24 (-0.13%)

DARSHANORNA

Darshan Orna

₹4.57image

₹5.07 (-0.10%)

Market Indices

Sensex

₹78,699.07image

₹78,472.48 (0.00%)

Source : Dion Global Solutions Limited